Liaoning Cheng Da Subsidiary to Invest $5 Million in Healthcare Fund
Liaoning Cheng Da (SHA:600739) subsidiary Chengda Steel Hong Kong will invest $5 million as a limited partner in a biopharmaceutical and healthcare fund, according to a Wednesday filing with the Shanghai bourse.The investment is equivalent to 12.95% of the Likon Venture Fund II Limited Partnership, which has so far raised $38.6 million.The fund will invest in innovative drugs, medical devices, medical diagnostic equipment and reagents, and related service areas.